|
[(4-Chlorophenyl)methyl][2-(pyrrolidin-1-yl)ethyl]amine dihydrochloride
|
|
105479-11-6
|
|
1-(2-Aminophenyl)-4-piperidinol
|
|
252758-96-6
|
|
Pararosaniline hydrochloride
|
|
569-61-9
|
|
(5-chloro-2-methoxyphenyl)(4-(4-chloro-3-methylphenyl)(2,5-thiazolyl))amine
|
|
1023834-21-0
|
|
Tenovin-6
|
|
1011557-82-6
|
|
(3-Isopropoxybenzyl)amine
|
|
400771-44-0
|
|
Methyl 3-(3-nitrophenyl)propanoate
|
|
22768-05-4
|
|
3-(4,5-Dimethyl-1H-pyrrol-3-yl)propan-1-amine
|
|
1368119-38-3
|
|
Ethyl 8-fluoro-1,2,3,4-tetrahydroquinoline-3-carboxylate
|
|
1706455-12-0
|
|
1-Acetyl-N,N-dimethylcyclopropane-1-sulfonamide
|
|
1896597-64-0
|
|
Abz-GIEPKSDPMPEQ-EDDnp
|
|
|
|
N-(4-(4-Hydroxyphenyl)thiazol-2-yl)acetamide
|
|
64309-02-0
|
|
1-(5-Bromothiophen-2-yl)ethan-1-amine hydrochloride
|
|
2137783-98-1
|
|
Complement C3 mouse Light
|
|
|
|
ACBD3 antibody
|
|
|
|
2-(1-Methyl-1H-pyrazol-4-yl)-2-oxoacetic acid
|
|
1134691-09-0
|
|
Biotin-(Arg8)-Vasopressin
|
|
|
|
4-(Allyloxy)-2-bromo-5-ethoxybenzoic acid
|
|
486994-79-0
|
|
3,3',5'-Triiodo-L-thyronine
|
|
5817-39-0
|
|
N-alpha-Allyloxycarbonyl-N-epsilon-2-Fmoc-L-lysine
|
|
186350-56-1
|
|
1-(1-Benzofuran-2-yl)cyclopropan-1-amine
|
|
1266172-97-7
|
|
2-Bromo-5-(4-methoxyphenyl)-1,3,4-thiadiazole
|
|
57709-54-3
|
|
SPG7 antibody
|
|
|
|
1-(2,3-Difluorophenyl)cyclopropanamine
|
|
1260667-54-6
|
|
D-Allo-isoleucine
|
|
1509-35-9
|
|
L-Fucose - non animal origin
|
|
2438-80-4
|
|
(E)-N-{1-[4-(1H-Imidazol-1-yl)phenyl]ethylidene}hydroxylamine
|
|
146139-83-5
|
|
(-)-Matairesinol
|
|
580-72-3
|
|
Artemis antibody
|
|
|
|
4-Ethyl-3-nitroaniline
|
|
51529-96-5
|
|
4H,6H,7H-Thiopyrano[4,3-d][1,3]thiazol-2-amine
|
|
61764-33-8
|
|
tert-Butyl 4-oxo-1,2-oxazolidine-2-carboxylate
|
|
2031259-21-7
|
|
Adenosine
|
|
58-61-7
|
|
2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
|
|
627906-52-9
|
|
3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-5-carbaldehyde
|
|
76799-25-2
|
|
Dovitinib Lactate Salt
|
|
692737-80-7
|
|
5-Phenyl-1,3,4-thiadiazole-2-carbaldehyde
|
|
99066-69-0
|
|
3-Bromo-6-methoxy-1,2-benzenediol
|
|
61559-82-8
|
|
1-{{[5-(4-Nitrophenyl)-2-furanyl]methylene}amino}-2,4-imidazolidinedione
|
|
7261-97-4
|
|
2-amino-1-(1-aza-4-(4-methoxyphenyl)buta-1,3-dienyl)ethene-1,2-dicarbonitrile
|
|
506435-25-2
|
|
3-(Oxolan-2-yl)morpholine
|
|
1803561-92-3
|
|
H-LTFDEYR^-OH
|
|
|
|
5-Amino-3-tert-butylisothiazole
|
|
89151-73-5
|
|
(2,4-Dichlorophenoxy)acetyl chloride
|
|
774-74-3
|
|
Isorhamnetin 3-sophoroside-7-rhamnoside
|
|
41328-75-0
|
|
MIND4-17
|
|
345989-24-4
|
|
TM 6089
|
|
863421-32-3
|
|
N-(3-Chlorophenyl)-1,1-dioxo-2,3-dihydrothiophen-3-amine
|
|
321977-85-9
|
|
4-Fluoro-3,5-diiodobenzaldehyde
|
|
879127-68-1
|
|
Prepro-Neuromedin U (104-136) (human)
|
|
|
|
(3-Chlorophenyl)(2-methylphenyl)methanamine
|
|
1049118-57-1
|
|
NHLRC1 antibody
|
|
|
|
RPS27L Blocking Peptide
|
|
|
|
5,6,7,8-Tetrahydroquinoline-4-carboxylic acid hydrochloride
|
|
1993217-72-3
|
|
1,2-Di-O-hexadecyl-rac-glycero-3-phosphoethanolamine
|
|
54285-60-8
|
|
Tetradecyl b-D-glucopyranoside
|
|
|
|
Hexahydro-1H-pyrrolo[2,1-c]morpholine-3-carbothioamide
|
|
1240529-47-8
|
|
LDLRAP1 Blocking Peptide
|
|
|
|
2-[(2-Aminoethyl)thio]ethanol
|
|
24304-84-5
|
|
S 2101
|
|
1239262-36-2
|
|
3-(1-Methyl-1H-pyrazol-5-yl)cyclopentan-1-one
|
|
1340410-90-3
|
|
5-Ethynyl-2-methoxy-1,3-thiazole
|
|
1849269-96-0
|
|
8-Methyladenosine
|
|
56973-12-7
|
|
1-(7Z-Hexadecenoyl)-rac-glycerol
|
|
749266-29-3
|
|
Eriosemation
|
|
162616-72-0
|
|
Z-Glu-Leu-OH·DCHA
|
|
252253-22-8
|
|
TGF beta 3 antibody
|
|
|
|
tert-Butyl (2S)-2-amino-4-methanesulfinylbutanoate
|
|
498565-47-2
|
|
UNC84A antibody
|
|
|
|
COPS6 antibody
|
|
|
|
COX18 antibody
|
|
|
|
5-(2-Methylcyclopropyl)furan-2-carbaldehyde
|
|
39763-79-6
|
|
Ethylene glycol dibenzoate
|
|
94-49-5
|
|
5-Azaspiro[3.4]octane-8-carboxylic acid hydrochloride
|
|
2361645-37-4
|
|
1-(Pyrimidin-2-yl)-1H-pyrazol-4-amine
|
|
1156601-73-8
|
|
1-(Oxolan-2-yl)-2-(piperazin-1-yl)ethan-1-ol dihydrochloride
|
|
1384427-53-5
|
|
3,3',5-Triiodo-L-thyronine sodium salt
|
|
55-06-1
|
|
KANK1 antibody
|
|
|
|
methyl 4,5-dimethoxy-2-(2-phenoxyacetylamino)benzoate
|
|
577985-78-5
|
|
2-Ethyltetrahydro-4H-pyran-4-one
|
|
36233-82-6
|
|
4-({[(tert-Butoxy)carbonyl]amino}methyl)cyclohex-1-ene-1-carboxylic acid
|
|
2168093-13-6
|
|
CD40 antibody (FITC)
|
|
|
|
Rerg Blocking Peptide
|
|
|
|
Des[(5-ethyl-2-pyridinyl)ethyl] pioglitazone dimer ether impurity
|
|
1391052-15-5
|
|
1-(Bromomethyl)-3-methoxy-5-methylbenzene
|
|
106116-42-1
|
|
5-[4-(4-Bromoanilino)anilino]-N'-(1-hydroxypropan-2-yl)-3-oxo-1,2-thiazole-4-carboximidamide
|
|
926906-64-1
|
|
N-[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide
|
|
252186-79-1
|
|
ELMOD1 antibody
|
|
|
|
Dengue VLP protein (Serotype 3)
|
|
|
|
5-(1,3-Dioxaindan-5-ylmethylidene)-3-(4-methylphenyl)-2-sulfanylideneimidazolidin-4-one
|
|
906128-02-7
|
|
3'-Bromo-4'-fluoro-β-methyl-β-nitrostyrene
|
|
1017083-55-4
|
|
4-Methyl-3-(pyrrolidin-1-yl)benzonitrile
|
|
1513149-33-1
|
|
Glycidyl oleate-d5
|
|
1426395-63-2
|
|
alpha-Dihydroartemisinin
|
|
81496-81-3
|
|
2,2'-Bipyridine-6,6'-dicarboxylic acid
|
|
4479-74-7
|
|
CACNG6 Blocking Peptide
|
|
|
|
4,4,5,5-Tetramethyl-2-[2-(thiophen-3-yl)ethenyl]-1,3,2-dioxaborolane
|
|
736987-75-0
|
|
2-(3-Methoxy-1,2-oxazol-5-yl)acetic acid
|
|
16877-55-7
|
|
TGFB3 Blocking Peptide
|
|
|
|
2-Phenylindolizine
|
|
25379-20-8
|